The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Primaquine revisited six decades after its discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
White, N. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421682 · Cited by 1,248
Antimalarial Drug Toxicity: A Review
Taylor, W. R. J., & White, N. J. (2004) · Drug Safety · doi:10.2165/00002018-200427010-00003 · Cited by 482
Primaquine Therapy for Malaria
Baird, J. K., & Hoffman, S. L. (2004) · Clinical Infectious Diseases · doi:10.1086/424663 · Cited by 435
Wiesner, J., Ortmann, R., Jomaa, H., & Schlitzer, M. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200569 · Cited by 428
Membrane Transport in the Malaria-Infected Erythrocyte
Kirk, K. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.495 · Cited by 405
The Hemolytic Effect of Primaquine and Related Compounds: a Review
BEUTLER, E. (1959) · Blood · doi:10.1182/blood.v14.2.103.103 · Cited by 395
Methemoglobin—It's not just blue: A concise review
Umbreit, J. (2007) · American Journal of Hematology · doi:10.1002/ajh.20738 · Cited by 385
Effectiveness of Antimalarial Drugs
Baird, J. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043207 · Cited by 375
van Weert, A. W., Dunn, K. W., Gueze, H. J., Maxfield, F. R., & Stoorvogel, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.821 · Cited by 335
PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I
HILL, D. R., BAIRD, J. K., PARISE, M. E., LEWIS, L. S., RYAN, E. T., & MAGILL, A. J. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.402 · Cited by 334
History, Dynamics, and Public Health Importance of Malaria Parasite Resistance
Talisuna, A. O., Bloland, P., & D’Alessandro, U. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.235-254.2004 · Cited by 322
Facilitation of AMPA Receptor Synaptic Delivery as a Molecular Mechanism for Cognitive Enhancement
Knafo, S., Venero, C., Sánchez-Puelles, C., Pereda-Peréz, I., Franco, A., Sandi, C., Suárez, L. M., Solís, J. M., Alonso-Nanclares, L., Martín, E. D., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001262 · Cited by 313
White, N. J., & Olliaro, P. L. (1996) · Parasitology Today · doi:10.1016/0169-4758(96)10055-7 · Cited by 307
Pharmacokinetics of Quinine, Chloroquine and Amodiaquine: Clinical Implications
Krishna, S., & White, N. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00002 · Cited by 304
Clinical Pharmacokinetics and Metabolism of Chloroquine: Focus on Recent Advancements
Ducharme, J., & Farinotti, R. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631040-00003 · Cited by 289
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Gametogenesis in Malaria Parasites Is Mediated by the cGMP-Dependent Protein Kinase
McRobert, L., Taylor, C. J., Deng, W., Fivelman, Q. L., Cummings, R. M., Polley, S. D., Billker, O., & Baker, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060139 · Cited by 244
The Origins of Antimalarial-Drug Resistance
Packard, R. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1403340 · Cited by 221
Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine
Singh, K. K., & Vingkar, S. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.035 · Cited by 215
Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity
Mangoni, M. L., Saugar, J. M., Dellisanti, M., Barra, D., Simmaco, M., & Rivas, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410795200 · Cited by 196
HYDE, J. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.08.020 · Cited by 189
Pukrittayakamee, S., Chotivanich, K., Chantra, A., Clemens, R. L., Looareesuwan, S., & White, N. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1329-1334.2004 · Cited by 178
Can primaquine therapy for vivax malaria be improved?
Baird, J. K., & Rieckmann, K. H. (2003) · Trends in Parasitology · doi:10.1016/s1471-4922(03)00005-9 · Cited by 169
Shanks, G. D., Oloo, A. J., Aleman, G. M., Ohrt, C., Klotz, F. W., Braitman, D., Horton, J., & Brueckner, R. (2001) · Clinical Infectious Diseases · doi:10.1086/324081 · Cited by 168
Mihaly, G., Ward, S., Edwards, G., Orme, M., & Breckenridge, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02369.x · Cited by 164
Antimalarial Chemotherapy. Mechanisms of Action, Resistance and New Directions in Drug Discovery
(2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg183 · Cited by 157
A PHASE II DOSE-INCREASING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA
Wasunna, M. K., RASHID, J. R., Mbui, J., Kirigi, G., Kinoti, D., Lodenyo, H. A., Felton, J. M., SABIN, A. J., & HORTON, J. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.871 · Cited by 150
Pharmacokinetic Interactions of Antimalarial Agents
Giao, P. T., & de Vries, P. J. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140050-00003 · Cited by 143
Malaria chemoprophylaxis with tafenoquine: a randomised study
Lell, B., Faucher, J., Missinou, M. A., Borrmann, S., Dangelmaier, O., Horton, J. D., & Kremsner, P. G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02352-7 · Cited by 143
Luque-Ortega, J. R., Hof, W. V. ‘., Veerman, E. C. I., Saugar, J. M., & Rivas, L. (2008) · The FASEB Journal · doi:10.1096/fj.07-096081 · Cited by 123
van Weert, A. W. M., Geuze, H. J., Groothuis, B., & Stoorvogel, W. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00062 · Cited by 117
Primaquine for Prevention of Malaria in Travelers
Baird, J. K., Fryauff, D. J., & Hoffman, S. L. (2003) · Clinical Infectious Diseases · doi:10.1086/379714 · Cited by 116
Antimalarial agents: mechanisms of action
Schlesinger, P. H., Krogstad, D. J., & Herwaldt, B. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.793 · Cited by 111
Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs
Brocks, D. R., & Mehvar, R. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00004 · Cited by 110
Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle
Sinden, R. E., & Smalley, M. E. (1979) · Parasitology · doi:10.1017/s003118200005335x · Cited by 108
Vennerstrom, J. L., Nuzum, E. O., Miller, R. E., Dorn, A., Gerena, L., Dande, P., Ellis, W. Y., Ridley, R. G., & Milhous, W. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.598 · Cited by 101
Mungthin, M., Bray, P. G., Ridley, R. G., & Ward, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2973 · Cited by 98
Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling.
Vasquez-Vivar, J. M., & Augusto, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50504-x · Cited by 95
Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine
Fletcher, K., Barton, P. F., & Kelly, J. A. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90263-8 · Cited by 95
Somasundaram, B., Norman, J. C., & Mahaut‐Smith, M. P. (1995) · Biochemical Journal · doi:10.1042/bj3090725 · Cited by 94
Imidazolidin-4-one Derivatives of Primaquine as Novel Transmission-Blocking Antimalarials
Araújo, M. J., Bom, J., Capela, R., Casimiro, C. M., Chambel, P., Gomes, P. A. C., Iley, J., Lopes, F., Morais, J., Moreira, R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0494624 · Cited by 89
Self-citationJain, M., Khan, S. I., Tekwani, B. L., Jacob, M. R., Singh, S., Singh, P. P., & Jain, R. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.034 · Cited by 87
Bowman, Z. S., Oatis, J. E., Whelan, J. L., Jollow, D. J., & McMillan, D. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062984 · Cited by 83
Stensrud, G., Sande, S. A., Kristensen, S., & Smistad, G. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00338-0 · Cited by 80
Schwartz, E., & Regev‐Yochay, G. (1999) · Clinical Infectious Diseases · doi:10.1086/313527 · Cited by 69
Gomes, P. A. C., Araújo, M. J., Rodrigues, M. J. E., Vale, N., Azevedo, Z., Iley, J., Chambel, P., Morais, J., & Moreira, R. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.04.077 · Cited by 68
Self-citationHiebsch, R. R., Raub, T. J., & Wattenberg, B. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54926-7 · Cited by 67
Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice
Júnior, J. M. R., Fessi, H., Bories, C., Puisieux, F., & Devissaguet, J. P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04135-4 · Cited by 66
Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy
Dierling, A. M., & Cui, Z. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.015 · Cited by 64
Inhibition of HERG potassium channels by the antimalarial agent halofantrine
Tie, H., Walker, B. D., Singleton, C. B., Valenzuela, S. M., Bursill, J. A., Wyse, K. R., Breit, S. N., & Campbell, T. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703470 · Cited by 62
Jain, M., Vangapandu, S., Sachdeva, S., Singh, S., Singh, P. P., Jena, G. B., Tikoo, K., Ramarao, P., Kaul, C. L., & Jain, R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0304562 · Cited by 61
Bates, M. D., Meshnick, S. R., Sigler, C. I., Leland, P., & Hollingdale, M. R. (1990) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1990.42.532 · Cited by 59
Luque-Ortega, J. R., Saugar, J. M., Chiva, C., et al. (2003) · Biochemical Journal · doi:10.1042/bj20030544 · Cited by 59
Antimalarial chemotherapy: Mechanisms of action, resistance, and new directions in drug discovery
Arnot, D. E. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90121-x · Cited by 57
Oxidative activity of primaquine metabolites on rat erythrocytes IN vitro and in vivo
Vasquez-Vivar, J. M., & Augusto, O. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90022-1 · Cited by 55
Pneumocystis carinii pneumonia: a clinical review.
Wilkin, A., & Feinberg, J. (1999) · PubMed · Cited by 53
Bowman, Z. S., Morrow, J. D., Jollow, D. J., & McMillan, D. C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086488 · Cited by 51
Silachamroon, U., Krudsood, S., Treeprasertsuk, S., Wilairatana, P., CHALEARMRULT, K., MINT, H. Y., Maneekan, P., White, N. J., GOURDEUK, V. R., Brittenham, G. M., et al. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.14 · Cited by 51
Peptide derivatives of primaquine as potential antimalarial agents
Abraham, P., Kepler, J. A., Johnson, B. H., & Carroll, F. I. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00399a032 · Cited by 48
Bapiro, T. E., Andersson, T. B., Otter, C. A., Hasler, J. A., & Masimirembwa, C. M. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0512-z · Cited by 47
Weed, R. I., Eber, J., & Rothstein, A. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104226 · Cited by 46
Allahyari, R., Strother, A., Fraser, I., & Verbiscar, A. J. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00369a031 · Cited by 45
LINK, C., Theoharides, A. D., Anders, J. C., Chung, H., & Canfield, C. J. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90155-3 · Cited by 44
Coker, S. J., Batey, A. J., Lightbown, I. D., Díaz, M. E., & Eisner, D. A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703060 · Cited by 44
A Novel Peptide-Grafted Liposomal Delivery System Targeted to Macrophages
Banerjee, G., Medda, S., & Basu, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.348 · Cited by 43
Nasveld, P., Kitchener, S. J., Edstein, M. D., & Rieckmann, K. H. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90351-2 · Cited by 42
TAFENOQUINE FOR THE TREATMENT OF RECURRENT PLASMODIUM VIVAX MALARIA
Kitchener, S. J., Nasveld, P., & Edstein, M. D. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.494 · Cited by 40
Diagnostic and Therapeutic Pitfalls Associated with Primaquine-Tolerant Plasmodium vivax
Spudick, J. M., Garcia, L. S., Graham, D. M., & Haake, D. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.978-981.2005 · Cited by 39
Kaur, K., Patel, S. R., Patil, P. R., Jain, M., Khan, S. I., Jacob, M. R., Ganesan, S., Tekwani, B. L., & Jain, R. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.036 · Cited by 38
Plasmepsin II inhibition and antiplasmodial activity of Primaquine–Statine `double-drugs'
Romeo, S., Dell’Agli, M., Parapini, S., Rizzi, L., Galli, G. V., Mondani, M., Sparatore, A., Taramelli, D., & Bosisio, E. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.030 · Cited by 37
Strother, A., Allahyari, R., Buchholz, J. N., Fraser, I., & Tilton, B. E. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07684-6 · Cited by 36
8-Quinolinamines and Their pro prodrug conjugates as potent blood-Schizontocidal antimalarial agents
Vangapandu, S., Sachdeva, S., Jain, M., Singh, S., Singh, P. P., Kaul, C. L., & Jain, R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.07.003 · Cited by 35
Vangapandu, S., Sachdeva, S., Jain, M., Singh, S., Singh, P. P., Kaul, C. L., & Jain, R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.028 · Cited by 35
Excretion, Distribution, and Metabolism of Primaquine in Rats
Clark, A. M., McChesney, J. D., & Baker, J. K. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730418 · Cited by 35
Carrier-linked primaquine in the chemotherapy of malaria
Hofsteenge, J., Capuano, A., Altszuler, R., & Moore, S. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00159a034 · Cited by 29
Binding of primaquine to epidermal membranes and keratin
Heard, C. M., Monk, B. V., & Modley, A. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00140-6 · Cited by 29
In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model
Kinnamon, K. E., Steck, E. A., Hanson, W. L., & Chapman, W. L. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00216a001 · Cited by 28
GREGORY, R. B., & Barritt, G. J. (1996) · Biochemical Journal · doi:10.1042/bj3190755 · Cited by 28
Chloroquine and primaquine: combining old drugs as a new weapon against falciparum malaria?
Egan, T. J. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.03.006 · Cited by 26
Bolchoz, L. J. C., Gelasco, A. K., Jollow, D. J., & McMillan, D. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041459 · Cited by 26
Biodegradable Microspheres. 17. Lysosomal Degradation of Primaquine–Peptide Spacer Arms
Borissova, R., Stjärnkvist, P., Karlsson, M. O., & Sjöholm, I. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840227 · Cited by 25
Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.
George, J. N., O’Brien, R. L., Pollack, S., & Crosby, W. H. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105435 · Cited by 23
Jain, M., Vangapandu, S., Sachdeva, S., & Jain, R. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.12.029 · Cited by 22
Methemoglobin Toxicity and Hematological Studies on Malaria Anti-Relapse Compound CDRI 80/53 in Dogs
Puri, S. K., Srivastava, R., Pandey, V. C., Sethi, N., & Dutta, G. P. (1989) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.41.638 · Cited by 22
Mayorga, P., Deharo, E., Puisieux, F., & Couarraze, G. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00151-8 · Cited by 19
Green, M. D., D’Souza, M. J., Holbrook, J. M., et al. (2004) · Journal of Microencapsulation · doi:10.1080/02652040410001729232 · Cited by 19
Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax
Kim, J. S., Oh, J., Chang, E.-A., Bae, S. Y., Nam, D. H., Lee, C. H., Yang, J. H., Lee, C. K., Lee, W. J., Kim, H. C., et al. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.01.002 · Cited by 15
Synthesis of some 4-substituted 8-amino-6-methoxyquinolines as potential antimalarials
Carroll, F. I., Berrang, B. D., Linn, C. P., & Twine, C. E. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00192a016 · Cited by 15
Antimalarials Inhibit Human Erythrocyte Membrane Acetylcholinesterase
Katewa, S. D., & Katyare, S. S. (2005) · Drug and Chemical Toxicology · doi:10.1080/01480540500262912 · Cited by 13
Antimalarial drugs inhibit the acetylcholine-receptor-operated potassium current in atrial myocytes
Hara, Y., & Kizaki, K. (2002) · Heart Lung and Circulation · doi:10.1046/j.1443-9506.2002.00128.x · Cited by 13
Cited by
Bousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746
Quinolines and structurally related heterocycles as antimalarials
Kaur, K., Jain, M., Reddy, R. P., & Jain, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.04.011 · Cited by 727
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Drugs: A review of promising novel corrosion inhibitors
Gece, G. (2011) · Corrosion Science · doi:10.1016/j.corsci.2011.08.006 · Cited by 565
Targeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
Metadata
- Authors
- Vale, N., Moreira, R., & Gomes, P.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 44
- Issue
- 3
- Pages
- 937-953
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1973828942
- Cited by
- 367
- References
- 90
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.